tm logo
NOVAROCK BIOTHERAPEUTICS
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 10 Jan 2022

Last Applicant/ Owned by

801 Charles Ewing Blvd.

Ewing

NJ

08628

Serial Number

87892684 filed on 25th Apr 2018

Registration Number

N/A

Correspondent Address

Brittany A. Estell

Morgan, Lewis & Bockius LLP

Attention: TMSU

1111 Pennsylvania Avenue, NW

Washington DC 20004-2541

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"BIOTHERAPEUTICS"

NOVAROCK BIOTHERAPEUTICS

The mark consists of the wording "NOVAROCK" in black lettering where the letters "N" and "R" are capitalized with the wording "BIOTHERAPEUTICS" underneath in smaller uppercase lettering. The letter "V" and the letter "I" are replaced with an aqua blue antibody symbol. Biotherapeutic preparations, namely, monoclonal antibodies for use in the treatment of cancer, hematological disorders, solid tumoRead More

Classification Information


Class [005]
Pharmaceutical Products


Biotherapeutic preparations, namely, monoclonal antibodies for use in the treatment of cancer, hematological disorders, solid tumors and autoimmune disorders

Mark Details


Serial Number

No 87892684

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of the wording "NOVAROCK" in black lettering where the letters "N" and "R" are capitalized with the wording "BIOTHERAPEUTICS" underneath in smaller uppercase lettering. The letter "V" and the letter "I" are replaced with an aqua blue antibody symbol.

Legal History


Show more

Status DateAction Taken
10th Jan 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
10th Jan 2022ABANDONMENT - NO USE STATEMENT FILED
03rd Jun 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01st Jun 2021TEAS EXTENSION RECEIVED
01st Jun 2021EXTENSION 4 GRANTED
01st Jun 2021EXTENSION 4 FILED
13th Apr 2021CORRECTED NOA E-MAILED
12th Apr 2021NOTICE OF ALLOWANCE CORRECTION ENTERED
12th Apr 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
02th Feb 2021TEAS POST PUBLICATION AMENDMENT RECEIVED